Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer
Giovanni Mantovani
◽
Antonio Maccio
◽
Carlo Mulas
◽
Elena Massa
◽
Clelia Madeddu
◽
...